Patent · US Active

Substituted nicotinamides as KCNQ2/3 modulators

US8586755B2 · kind B2 · utility

2Cited by

4References

11Claims

0Family size

Assignee

GRÜNENTHAL GMBH · DE

Inventors

Sven Kühnert · St. Blasien, DE
Beatrix Merla · Aachen, DE
Gregor Bahrenberg · Monschau, DE
Wolfgang Schröder · Aachen, DE

Key dates

Filing date	Mar 30, 2012
Grant date	Nov 19, 2013
Priority date	—
Expiry date	Mar 30, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Substituted nicotinamides, processes for their preparation, medicaments comprising these compounds and methods of using these compounds to treat pain, epilepsy, urinary incontinence, anxiety, dependency, mania, bipolar disorders, migraine, cognitive diseases, and/or dystonia-associated dyskinesias.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.